WebABSTRACT Study Objectives: To evaluate the utility of a contact-free device in screening for obstructive sleep apnea (OSA). Methods: 359 participants (mean age was 46 ± 13 years old, BMI was 26.1 ± 4.2 kg/m2, and 67.7% were male) underwent an overnight monitoring using a contact-free device, OrbSense, and polysomnography (PSG) in the sleep lab simultaneously. WebOct 7, 2013 · Thomas Penzel, Interdisciplinary Sleep Medicine Center Charité—Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. ... but also PhD and MSc health professionals such as clinical psychologists and scientists, technologists and nurses, all of whom may be involved professionally in sleep medicine.
Thomas Penzel (0000-0002-4304-0112) - ORCID
WebOct 5, 2024 · Dr Penzel reported receiving consulting fees from Bayer Healthcare and Cerebra, speaker fees from Jazz Pharma and Neuwirth Medical, and grants from Loewenstein Medical outside the submitted work. Dr Ewert reported receiving grants from OMT Germany and personal fees from Bayer Vital Germany, GSK Germany, AstraZeneca … WebMar 20, 2024 · Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email. how to overcome texting anxiety
Defining Extreme Phenotypes of OSA Across International
WebJan 4, 2024 · List of computer science publications by Thomas Penzel. Christoph Schöbel, Ingo Fietze, Thomas Penzel: Effects of optimized heart failure medication on central sleep apnea with Cheyne-Stokes respiration pattern in chronic heart failure with reduced left-ventricular ejection fraction. WebMar 10, 1999 · Thomas Penzel PhD. Sleep Laboratory, Department of Medicine, Marburg University, Department of Physiology, Philipps-Universität Marburg University, Marburg, Germany. Merckle GmbH, Clinical Research Department, Ulm, Germany. Search for more papers by this author WebNumber of Hits and Downloads for This Article Total Article Views (10791) All Articles published online mwwc message board hub